Condition
High Grade Ovarian Serous Adenocarcinoma clinical trials and research
As of November 12, 2026, Find a Trial lists 5 High Grade Ovarian Serous Adenocarcinoma clinical trials that are recruiting, at sites in 4 countries (most in United States (2), Canada (1), Finland (1)). By phase: Phase 2 (1), Phase 1 (1), Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 4Countries
Newest High Grade Ovarian Serous Adenocarcinoma clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Testing ZM008 alone and with Pembrolizumab in patients with advanced solid tumors | Phase 1 | Boston, Massachusetts and 2 other locations | Recruiting | Jun 11, 2024 |
| Testing a new dosing method of niraparib for ovarian cancer treatment | Phase 2 | Toronto, Ontario | Recruiting | Jul 27, 2023 |
| Modi-1 vaccine for advanced cancers | Phase 1/2 | Brighton, Default and 15 other locations | Recruiting | Apr 15, 2022 |
| Improving diagnosis and treatment for advanced ovarian cancer | — | Turku | Recruiting | Apr 15, 2021 |
| Using a uterine wash and a blood protein test to find ovarian cancer early | — | Little Rock, Arkansas and 5 other locations | Recruiting | Mar 12, 2021 |
All recruiting trials (5)
-
Testing ZM008 alone and with Pembrolizumab in patients with advanced solid tumors
This study is testing a new treatment called ZM008, alone and with another drug called Pembrolizumab, to see if it can help patients with advanced solid tumors who have run out of other treatment options.
-
Testing a new dosing method of niraparib for ovarian cancer treatment
This study is testing a new way to give niraparib to see if it helps people with newly diagnosed advanced ovarian cancer stay healthy longer after their initial chemotherapy.
-
Modi-1 vaccine for advanced cancers
This study is testing a new vaccine for people with advanced cancers like triple negative breast cancer and ovarian cancer to see if it can boost their immune response and work better with other treatments.
-
Improving diagnosis and treatment for advanced ovarian cancer
This study is testing personalized treatment plans for newly diagnosed advanced ovarian cancer patients who may not respond well to standard chemotherapy to see if it can improve their outcomes.
-
Using a uterine wash and a blood protein test to find ovarian cancer early
This project will try to find tumor DNA in a uterine wash plus protein markers in blood to detect ovarian or fallopian tube cancer in women having surgery for a suspected ovarian growth or BRCA1/2 carriers having risk-reducing surgery.
Related topics
Quick answers
How many High Grade Ovarian Serous Adenocarcinoma clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in United States (2 trials), Canada (1 trial), Finland (1 trial), United Kingdom (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1, Phase 1: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.